Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
messenger RNA
Biotech
Pfizer's mRNA flu vaccine hits primary goals in phase 3 trial
Pfizer found its “candidate demonstrated non-inferiority and superiority to a licensed flu vaccine at the time of the primary analysis.”
Nick Paul Taylor
Oct 31, 2023 7:53am
Pfizer, BioNTech prep flu-COVID mRNA combo vaccine for phase 3
Oct 26, 2023 9:32am
Sanofi, BioNTech scrap mRNA cancer drug based on early data
Jul 28, 2023 6:53am
Moderna’s protein replacement therapy passes early clinical test
May 19, 2023 10:10am
CureVac posts mRNA flu, COVID-19 vaccine data in older adults
Jan 30, 2023 9:35am
AbbVie pays Anima $42M to go after undruggable targets
Jan 10, 2023 9:15am